| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $158,000 | 5 | 100 |
Sells | $0 | 0 | 0 |
| Gary M. Huff | director | 1 | $50,000 | 0 | $0 | $50,000 |
| Irani Zackary S. | Chief Executive Officer | 1 | $50,000 | 0 | $0 | $50,000 |
| BARBIERI ALLEN | Executive Vice Chairman | 1 | $32,000 | 0 | $0 | $32,000 |
| MOATAZEDI DAVID | director | 1 | $16,000 | 0 | $0 | $16,000 |
| Chin Eric | director | 1 | $10,000 | 0 | $0 | $10,000 |
Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications. These kits are also capable of quantifying minute concentrations of specific substances like bacteria, hormones, antibodies, antigens, or other …
Over the last 12 months, insiders at Biomerica, Inc. have bought $158,000 and sold $0 worth of Biomerica, Inc. stock.
On average, over the past 5 years, insiders at Biomerica, Inc. have bought $99,954 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Gary M. Huff (director) — $50,000. Irani Zackary S. (Chief Executive Officer) — $50,000. BARBIERI ALLEN (Executive Vice Chairman) — $32,000.
The last purchase of 31,250 shares for transaction amount of $50,000 was made by Irani Zackary S. (Chief Executive Officer) on 2026‑08‑26.
| 2026-08-26 | Irani Zackary S. | Chief Executive Officer | 31,250 0.9574% | $1.60 | $50,000 | +25.44% | ||
| 2026-08-26 | BARBIERI ALLEN | Executive Vice Chairman | 20,000 0.6128% | $1.60 | $32,000 | +25.44% | ||
| 2026-08-26 | MOATAZEDI DAVID | director | 10,000 0.3064% | $1.60 | $16,000 | +25.44% | ||
| 2026-08-26 | Chin Eric | director | 6,250 0.1915% | $1.60 | $10,000 | +25.44% | ||
| 2026-08-20 | Gary M. Huff | director | 31,250 1.0446% | $1.60 | $50,000 | +31.45% | ||
| 2023-05-25 | Irani Zackary S. | Chief Executive Officer | 200 0.0015% | $1.55 | $310 | -34.64% | ||
| 2023-05-24 | Irani Zackary S. | Chief Executive Officer | 500 0.0037% | $1.61 | $805 | -37.65% | ||
| 2023-05-12 | Irani Zackary S. | Chief Executive Officer | 1,700 0.0132% | $1.17 | $1,989 | -6.25% | ||
| 2023-05-10 | Irani Zackary S. | Chief Executive Officer | 500 0.0038% | $1.27 | $635 | -16.00% | ||
| 2023-05-09 | Irani Zackary S. | Chief Executive Officer | 300 0.0024% | $1.39 | $417 | -18.22% | ||
| 2023-05-04 | Irani Zackary S. | Chief Executive Officer | 1,000 0.0073% | $1.36 | $1,360 | -23.19% | ||
| 2023-04-28 | Irani Zackary S. | Chief Executive Officer | 1,800 0.0135% | $1.34 | $2,412 | -18.80% | ||
| 2023-04-27 | Irani Zackary S. | Chief Executive Officer | 2,600 0.0194% | $1.31 | $3,406 | -16.92% | ||
| 2023-04-26 | Irani Zackary S. | Chief Executive Officer | 7,000 0.0528% | $1.26 | $8,820 | -12.50% | ||
| 2023-01-27 | BARBIERI ALLEN | Executive Vice Chairman | 1,538 0.0116% | $2.94 | $4,522 | -55.69% | ||
| 2023-01-26 | Coste Catherine | director | 2,190 0.016% | $2.96 | $6,482 | -57.00% | ||
| 2023-01-25 | Irani Zackary S. | Chief Executive Officer | 1,800 0.013% | $2.85 | $5,130 | -55.82% | ||
| 2023-01-24 | Irani Zackary S. | Chief Executive Officer | 2,000 0.0149% | $2.81 | $5,620 | -53.93% | ||
| 2020-10-26 | Coste Catherine | director | 9,100 0.0773% | $5.45 | $49,595 | -8.79% | ||
| 2020-04-21 | Sale | Sirgo Mark A | director | 5,000 0.0429% | $8.11 | $40,532 | -16.09% |
| Irani Zackary S. | Chief Executive Officer | 242570 5.2744% | $412,369.00 | 35 | 0 | <0.0001% |
| BARBIERI ALLEN | Executive Vice Chairman | 73542 1.5991% | $125,021.40 | 4 | 0 | <0.0001% |
| Gary M. Huff | director | 51250 1.1144% | $87,125.00 | 1 | 0 | |
| MOATAZEDI DAVID | director | 40625 0.8834% | $69,062.50 | 1 | 0 | |
| Chin Eric | director | 38750 0.8426% | $65,875.00 | 1 | 0 | |
| MOORE JANET TRUST DTD 8/21/98 | 635977 13.8287% | $1.08M | 1 | 0 | <0.0001% | |
| IRANI ZACKARY | Chief Executive Officer | 271526 5.9041% | $461,594.20 | 1 | 0 | |
| MOORE JANET | Chief Financial Officer | 140720 3.0598% | $239,224.00 | 2 | 6 | <0.0001% |
| CANO FRANCIS | director | 133736 2.908% | $227,351.20 | 7 | 0 | <0.0001% |
| Coste Catherine | director | 43790 0.9522% | $74,443.00 | 2 | 0 | <0.0001% |
| Emerson Jane | director | 21000 0.4566% | $35,700.00 | 1 | 0 | <0.0001% |
| Sirgo Mark A | director | 8700 0.1892% | $14,790.00 | 3 | 2 | +21.92% |
| Increased Positions | 5 | +26.32% | 14,017 | +12.77% |
| Decreased Positions | 6 | -31.58% | 34,323 | -31.27% |
| New Positions | 0 | New | 0 | New |
| Sold Out Positions | 5 | Sold Out | 31,967 | Sold Out |
| Total Postitions | 18 | -5.26% | 89,452 | -18.5% |
| Vanguard Group Inc | $53.00 | 0.7% | 21,127 | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $53.00 | 0.7% | 20,983 | -680 | -3.14% | 2025-09-30 |
| Blackrock, Inc. | $47.00 | 0.62% | 18,636 | 0 | 0% | 2025-09-30 |
| Two Sigma Securities, Llc | $26.00 | 0.35% | 10,472 | +10,472 | New | 2025-09-30 |
| Drw Securities, Llc | $26.00 | 0.35% | 10,392 | +10,392 | New | 2025-09-30 |
| Newedge Advisors, Llc | $9.00 | 0.12% | 3,603 | 0 | 0% | 2025-09-30 |
| Hollencrest Capital Management | $4.00 | 0.05% | 1,450 | 0 | 0% | 2025-09-30 |
| Citigroup Inc | $2.00 | 0.03% | 800 | +800 | New | 2025-09-30 |
| Cibc Private Wealth Group Llc | $1.00 | 0.02% | 512 | +100 | +24.27% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $0 | 0.01% | 194 | +194 | New | 2025-09-30 |